Ipilimumab
Quiénes somos
Efficacy and Safety of Two Combination Treatment Regimens of Nivolumab and Ipilimumab in Patients With dMMR and / or MSI Metastatic Colorectal Cancer ( NIPISAFE )
Pooled Mutant KRAS-Targeted Long Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Resected MMR-p Colorectal and Pancreatic Cancer
A Study of a Personalized Neoantigen Vaccine in Combination With Immune Checkpoint Blockade for Patients With Metastatic Colorectal Cancer
Estudio de BMS-986253 en combinación con nivolumab o nivolumab más ipilimumab en cánceres avanzados.
The Rome Trial From Histology to Target: the Road to Personalize Target Therapy and Immunotherapy
Regorafenib, Ipilimumab and Nivolumab for the Treatment of Chemotherapy Resistant Microsatellite Stable Metastatic Colorectal Cancer
Adoptive Cell Therapy Across Cancer Diagnoses
Interleucina-15 recombinante en combinación con los inhibidores de puntos de control nivolumab e ipilimumab en pacientes con cáncer refractario
Nivolumab e Ipilimumab y radioterapia en cáncer colorrectal y de páncreas con MSS y MSI alto
Ipilimumab, Maraviroc and Nivolumab (LUMINESCENCE)
